APA (7th ed.) Citation

J, K., KM, W., ML, R., O, R., R, Q., A, N., . . . AK, A. (2023). Structures of SARS-CoV-2 N7-methyltransferase with DOT1L and PRMT7 inhibitors provide a platform for new antivirals. PLoS pathogens, 19(7), e1011546. https://doi.org/10.1371/journal.ppat.1011546

Chicago Style (17th ed.) Citation

J, Kottur, White KM, Rodriguez ML, Rechkoblit O, Quintana-Feliciano R, Nayar A, García-Sastre A, and Aggarwal AK. "Structures of SARS-CoV-2 N7-methyltransferase with DOT1L and PRMT7 Inhibitors Provide a Platform for New Antivirals." PLoS Pathogens 19, no. 7 (2023): e1011546. https://doi.org/10.1371/journal.ppat.1011546.

MLA (9th ed.) Citation

J, Kottur, et al. "Structures of SARS-CoV-2 N7-methyltransferase with DOT1L and PRMT7 Inhibitors Provide a Platform for New Antivirals." PLoS Pathogens, vol. 19, no. 7, 2023, p. e1011546, https://doi.org/10.1371/journal.ppat.1011546.